H2AX and Hutchinson-Gilford progeria syndrome: Our findings are consistent with data from another group using the HGPS patient line HGADFN167, which displayed a reduced ability to generate γ‐H2AX in response to the DNA‐damaging drugs, such as doxorubicin and camptothecin (Zhang et al., 2016).